| Lonafarnib - Wikipedia, the free encyclopedia Lonafarnib is a farnesyl-OH-transferase inhibitor that is being investigated in a human clinical trial as a potential treatment for progeria. Laminopathy This ... Read More |
| Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for ... This is an open label dose adjusted phase II trial of the oral farnesyltransferase inhibitor (FTI) lonafarnib (SCH66336) for patients with HGPS and progeroid ... Read More |
| Lonafarnib | CAS#193275-84-2 | MedKoo Biosciences Other drug agents. Drug intermediates. Bio-reagents and biochemicals . MedKoo product information: Lonafarnib . Description of Lonafarnib: Lonafarnib is a farnesyl ... Read More |
| Lonafarnib (SCH66336) improves the activity of temozolomide and ... 1. J Neurooncol. 2011 Aug;104(1):179-89. Epub 2011 Jan 19. Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas. Read More |
| Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with ... Abstract. Purpose: To establish the maximum tolerated dose of the farnesyltransferase inhibitor lonafarnib (Sarasar, Schering-Plough Corp., Kenilworth ... Read More |
| lonafarnib - PubChem Structure, classification, information, physical and chemical properties for Sarasar, Sch66336, Sch 66336, Lonafarnib [USAN], Sch-66336, 1o5m, AC1L3WMQ, Lonafarnib ... Read More |
| A phase I safety, pharmacological, and biological study of the ... A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and ... Read More |
| Leukemia - Hyperleukocytosis complicating lonafarnib treatment in ... Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and ... Read More |
| Lonafarnib in Metastatic Breast Cancer - Full Text View ... A published phase 2 study reported that lonafarnib was administered as a single agent via continuous or intermittent oral dosing to 76 women with advanced breast ... Read More |
| Farnesyltransferase inhibitor - Wikipedia, the free encyclopedia SCH66336 (Lonafarnib) was the first to do so, followed by R115777 (Zarnestra, Tipifarnib). Unfortunately, the predicted “early potential [of FTIs] has not been realised ... Read More |
